Key result
Catheter ablation has evolved significantly with technological advancements, becoming a first-line therapeutic choice for many supraventricular arrhythmias.
Technological advancements in catheter ablation have increased its success rates and safety, establishing it as a first-line therapy for many supraventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Supports first-line ablation for supraventricular arrhythmias; leaves open need for prospective validation of newest technologies.
Radiofrequency ablation of cardiac arrhythmias has come to widespread use since it was first performed in the mid-1980s. Together with an increasing understanding of arrhythmia mechanisms both at the atrial and ventricular levels, technology has made tremendous progress. With improvements in catheter materials and function, development of different energy sources, and the advance of mapping techniques, catheter ablation can nowadays be used to cure all types of arrhythmia including focally induced atrial and ventricular fibrillation. With the most recent innovations in the integration of mapping and cardiac imaging, robotic and magnetic navigation, success rates and safety of catheter ablation have greatly increased. Catheter ablation has become not only an alternative to drug therapy in the treatment of supraventricular arrhythmias, but is nowadays in many cases the first therapeutic choice. In the future, the reduction of radiation exposure by using non-fluoroscopic imaging and robotic navigation will further advance this curative approach.
No takes yet. Share an insight, caveat, or question.
Wolpert et al. (2007) conducted a review in Cardiac arrhythmias. Catheter ablation was evaluated. Catheter ablation has evolved significantly with technological advancements, becoming a first-line therapeutic choice for many supraventricular arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: